Evidence map›Paper›PMID 41767951›Full record

ArticlemLife2026

Berberrubine inhibits

Minzhi Jiang, Changyu Wang, Kai Wang, Xinchi Feng, Gen Li, Yu Jiang, Xue Wang, Shijie Cao, Liqin Ding, Shuangyu Bi and 3 more

Abstract readLetter
In one paragraph

Article in mLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Minzhi JiangState Key Laboratory of Microbial Technology Shandong University Qingdao China.ORCID https://orcid.org/0000-0002-6859-7398
Changyu WangDivision of Life Sciences and Medicine University of Science and Technology of China Hefei China.
Kai WangSchool of Chinese Materia Medica, and Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China.
Xinchi FengSchool of Chinese Materia Medica, and Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China.
Gen LiSchool of Chinese Materia Medica, and Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China.
Yu JiangState Key Laboratory of Microbial Technology Shandong University Qingdao China.
Xue WangState Key Laboratory of Microbial Technology Shandong University Qingdao China.
Shijie CaoState Key Laboratory of Component-based Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China.
Liqin DingState Key Laboratory of Component-based Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China.
Shuangyu BiState Key Laboratory of Microbial Technology Shandong University Qingdao China.
Feng QiuSchool of Chinese Materia Medica, and Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China.
Shuang-Jiang LiuState Key Laboratory of Microbial Technology Shandong University Qingdao China.
Chang LiuState Key Laboratory of Microbial Technology Shandong University Qingdao China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41767951
PMCPMC12948479

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.